CPT vs LAB · P/E 104, rev $7.1M vs rev $174.4M
Camden Property Trust (CPT) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CPT and LAB stock pages for the full models.
Not investment advice.